Market Overview:
The global gastrointestinal bleeding treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of gastrointestinal diseases, increasing awareness about early diagnosis and treatment of gastrointestinal bleeding, and technological advancements in the field of endoscopy. However, the high cost associated with diagnosis and treatment is expected to restrain the growth of this market during the forecast period. The global gastrointestinal bleeding treatment market can be segmented on the basis of type into upper GI tract and lower GI tract. On the basis of application, it can be divided into hospitals, clinics, ambulatory surgical centers (ASCs), and others (including research institutes). Geographically, it can be segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
Gastrointestinal bleeding (GI bleeding) treatment is the medical care given to a person who has lost blood from the gastrointestinal tract. Treatment may include stopping the source of the bleeding, replacing lost blood, and repairing any damage to the GI tract.
Upper GI Tract:
Upper GI tract, also known as the upper gastrointestinal tract is a part of the digestive system and includes organs such as liver & gallbladder, biliary system (Bile ducts and Bile channels), pancreatic duct, common & duodenal arteries. The upper GI tract serves mainly to digest food in the stomach before it is absorbed by the small intestine. It also plays an important role in removing toxins from the body; hence it is very essential for human health.
Lower GI Tract:
The lower gastrointestinal tract (GI tract) consists of the stomach, small intestine, and large intestine. The lower GI tract is used in the treatment of gastrointestinal bleeding. A person may suffer from blood loss due to several reasons such as heavy menstrual bleeding or injury caused by a cut or burn. In such cases, if not treated at an early stage then it may lead to severe conditions including life-threatening internal hemorrhage (bleeding) and external hemorrhage (loss of blood).
Application Insights:
Based on application, the market is segmented into hospitals, clinics, ambulatory surgical centers and others. The hospital segment dominated the overall market in terms of revenue in 2017 owing to factors such as availability of advanced healthcare facilities and highly skilled staff at hospitals. Furthermore, gastroscopies are conducted more frequently at hospitals due to high patient traffic which encourages diagnosis early and treatment initiation for timely management of GI bleeding.
The clinics segment is expected to witness lucrative growth over the forecast period owing to increasing awareness about better treatment options for gastrointestinal (GI) bleeding disorders among patients across the globe. Increasing prevalence rates coupled with rising demand for effective treatments are anticipated drive demand from clinics over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing prevalence of lifestyle-associated diseases, rising adoption of new technologies, and presence of well-established healthcare facilities in this region. Moreover, high demand for minimally invasive surgeries is also driving the regional market growth. In addition, growing awareness about various treatment options available for gastrointestinal bleeding disorder is further expected to propel regional demand during the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and economic development in emerging countries like China and India that are majorly contributing towards overall Asia Pacific Gastrointestinal Bleeding Treatment Market Growth Trending Key Factors Segmentation of key players operating within this industry include medical & surgical centers; ambulatory surgery centers; hospitals & clinics; diagnostic laboratories; pharmaceutical companies & other service providers (hospitals). These factors are likely to contribute toward regional growth during the estimated time frame.
Growth Factors:
- Increasing incidence of gastrointestinal bleeding
- Rising geriatric population
- Growing demand for minimally invasive procedures
- Technological advancements in gastrointestinal bleeding treatment methods
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Gastrointestinal Bleeding Treatment Market Research Report
By Type
Upper GI Tract, Lower GI Tract
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Others
By Companies
Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS PLC, US Medical Innovations, LLC.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Gastrointestinal Bleeding Treatment Market Report Segments:
The global Gastrointestinal Bleeding Treatment market is segmented on the basis of:
Types
Upper GI Tract, Lower GI Tract
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific Corporation
- Olympus Corporation
- CONMED Corporation
- Cook Medical
- Ovesco Endoscopy AG
- Erbe Elektromedizin GmbH
- STERIS PLC
- US Medical Innovations, LLC.
Highlights of The Gastrointestinal Bleeding Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Upper GI Tract
- Lower GI Tract
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gastrointestinal Bleeding Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gastrointestinal bleeding is a condition in which blood leaks from the stomach or intestines. This can happen for many reasons, including injury, surgery, or disease. Treatment depends on the cause of the bleeding and may include antibiotics to prevent infection, pain relief medication, and blood transfusions if necessary.
Some of the major companies in the gastrointestinal bleeding treatment market are Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS PLC, US Medical Innovations, LLC..
The gastrointestinal bleeding treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gastrointestinal Bleeding Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gastrointestinal Bleeding Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gastrointestinal Bleeding Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gastrointestinal Bleeding Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gastrointestinal Bleeding Treatment Market Size & Forecast, 2018-2028
4.5.1 Gastrointestinal Bleeding Treatment Market Size and Y-o-Y Growth
4.5.2 Gastrointestinal Bleeding Treatment Market Absolute $ Opportunity
Chapter 5 Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gastrointestinal Bleeding Treatment Market Size Forecast by Type
5.2.1 Upper GI Tract
5.2.2 Lower GI Tract
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gastrointestinal Bleeding Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gastrointestinal Bleeding Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gastrointestinal Bleeding Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Gastrointestinal Bleeding Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gastrointestinal Bleeding Treatment Market Size Forecast by Type
9.6.1 Upper GI Tract
9.6.2 Lower GI Tract
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gastrointestinal Bleeding Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gastrointestinal Bleeding Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Gastrointestinal Bleeding Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gastrointestinal Bleeding Treatment Market Size Forecast by Type
10.6.1 Upper GI Tract
10.6.2 Lower GI Tract
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gastrointestinal Bleeding Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gastrointestinal Bleeding Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gastrointestinal Bleeding Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gastrointestinal Bleeding Treatment Market Size Forecast by Type
11.6.1 Upper GI Tract
11.6.2 Lower GI Tract
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gastrointestinal Bleeding Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gastrointestinal Bleeding Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Gastrointestinal Bleeding Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gastrointestinal Bleeding Treatment Market Size Forecast by Type
12.6.1 Upper GI Tract
12.6.2 Lower GI Tract
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gastrointestinal Bleeding Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gastrointestinal Bleeding Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gastrointestinal Bleeding Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gastrointestinal Bleeding Treatment Market Size Forecast by Type
13.6.1 Upper GI Tract
13.6.2 Lower GI Tract
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gastrointestinal Bleeding Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gastrointestinal Bleeding Treatment Market: Competitive Dashboard
14.2 Global Gastrointestinal Bleeding Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific Corporation
14.3.2 Olympus Corporation
14.3.3 CONMED Corporation
14.3.4 Cook Medical
14.3.5 Ovesco Endoscopy AG
14.3.6 Erbe Elektromedizin GmbH
14.3.7 STERIS PLC
14.3.8 US Medical Innovations, LLC.
